Cyclo(RGDyK)
αVβ3 integrin inhibitor
Product Specifications
CAS Number
250612-42-1
Product Name Alternative
2,2,2-trifluoroacetic acid compound with 2-((1Z,2S,3Z,5R,6Z,8S,9Z,11S,12Z)-8-(4-aminobutyl)-11-(3-guanidinopropyl)-3,6,9,12,15-pentahydroxy-5-(4-hydroxybenzyl)-1,4,7,10,13-pentaazacyclopentadeca-3,6,9,12,15-pentaen-2-yl)acetic acid (2:1)
Purity
0.9804
Form
A solid
Solubility
insoluble in EtOH; ≥50.2 mg/mL in H2O with ultrasonic; ≥6.347 mg/mL in DMSO with gentle warming and ultrasonic
Smiles
NCCCC[C@@]1([H])/C(O)=N/[C@@](/C(O)=N/C/C(O)=N/[C@@](/C(O)=N/[C@](/C(O)=N/1)([H])CC2=CC=C(O)C=C2)([H])CC(O)=O)([H])CCCNC(N)=N.FC(F)(F)C(O)=O.FC(F)(F)C(O)=O
Molecular Formula
C31H43F6N9O12
Molecular Weight
847.72
Shipping Conditions
Blue ice
Storage Conditions
Store at -20°C.
More Discoveries
Explore Other Products
Browse additional items from our catalog
226422-01 50 µL
TPX2 (Targeting Protein for Xklp2, Differentially expressed in Cancerous and non-Cancerous lung Cells 2, DIL-2, HepatoCellular Carcinoma-Associated Antigen 519, Protein fls353, Restricted Expression Proliferation-Associated Protein 100, p100, TPX2, C20orf1, C20orf2, DIL2, HCA519) discontinued
Sign In for Pricing
View Details 226422-02 100 µL
TPX2 (Targeting Protein for Xklp2, Differentially expressed in Cancerous and non-Cancerous lung Cells 2, DIL-2, HepatoCellular Carcinoma-Associated Antigen 519, Protein fls353, Restricted Expression Proliferation-Associated Protein 100, p100, TPX2, C20orf1, C20orf2, DIL2, HCA519) discontinued
Sign In for Pricing
View Details 